Nationwide Recall of Prescription Eye Drops Due to Contamination Risk

Overview of the Recall

Over 2.5 million bottles of a popular prescription eye drop medication have been recalled across the country after the manufacturer detected a potential foreign substance in the product, as reported by the Food and Drug Administration (FDA). The eye drops in question are Prednisolone Acetate Ophthalmic Suspension, which is frequently prescribed for alleviating allergy symptoms and eye inflammation. Lupin Pharmaceuticals Inc. has initiated this voluntary recall after identifying the contamination concern.

To provide context, the Mayo Clinic describes prednisolone as a steroid medication that helps reduce redness, itching, and swelling associated with eye infections and similar conditions. It is important to note that this medication is available only through a doctor's prescription.

Recall Details

Specifics of the Recalled Product

The recall notice specifies that the affected product is labeled as prednisoLONE Acetate Ophthalmic Suspension, USP, 1%, and is available by prescription only. The recall encompasses three different bottle sizes: 5 mL, 10 mL, and 15 mL, each associated with its own National Drug Code number. These bottles were produced by Lupin Limited at their facility located in Pithampur, India. In total, the recall impacts 2,530,182 bottles, and it has been assigned the recall number D-0655-2026.

Timeline and Risk Assessment

Classification of the Recall

The recall process began discreetly last month but was only officially designated as a Class II recall last week. This classification indicates that the recall affects a broad range of lot codes, meaning it pertains to multiple batches and bottles rather than just one production run. The FDA categorizes a Class II recall as one where the product may lead to health issues that are temporary or reversible with appropriate treatment. This classification is less severe than a Class I recall, which is reserved for cases that could result in serious injury or death. Nonetheless, the decision by Lupin to recall millions of bottles underscores the seriousness of the situation. Patients who possess this medication can check the lot number on their bottles against the numbers provided in the FDA's recall notice.